Project Grant HT94252510370
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$221K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
This Project Grant award of $2,037,497.00 from the Defense Health Agency was made to Michigan State University on September 30, 2023. The purpose of the grant is to transform behavioral health care to improve the quality of life for individuals with childhood-onset lupus. The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for service members and the public. As...
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...
The Defense Health Agency awarded a $553,588 Project Grant to Michigan State University on September 1, 2023 to conduct research on "NEUROBIOLOGICAL MECHANISMS TO ALLEVIATE COMORBID PAIN AND OBESITY." This Project Grant is funded through the Military Medical Research and Development program (CFDA 12.420) which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. As the prime awardee, Michigan State University...
The Michigan State University was awarded a $704,249 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research from July 2021 to June 2024 to uncover mechanisms underlying cognitive changes and sleep in neurofibromatosis type 1 (NF1). The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $810,032 to Michigan State University to conduct research on neurobiological mechanisms to alleviate comorbid pain and obesity. The research will take place at Michigan State University's campus in East Lansing, Michigan and is expected to be completed by August 31, 2027. No details were provided on any sub-award recipients or services delivered under the grant.
This federal Project Grant award of $932,498.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. Specifically, the award to the Regents of the University of Michigan will fund a research project titled "Non-Invasive CNS Delivery of Immunocytokines for Sustained Expansion of Tregs and Treatment of ALS". The research...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,460,000 Project Grant to Louisiana State University (LSU) Health Sciences Center-Shreveport. The grant supports research to investigate photobiomodulation therapy as a potential treatment strategy for post-traumatic stress disorder. The award includes a subaward to the University of Arizona Health Sciences to incorporate their expertise. The grant period runs from September 1, 2024 to...
This federal Project Grant award of $1,499,998.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Michigan State University (MSU). The grant is focused on "Addressing Disproportionate Burden Among Women: Early Monitoring of Symptoms After ACL Injury to Prevent Post-Traumatic Osteoarthritis". The objective is to conduct advanced biomedical research to transform healthcare for military service members, veterans, and...
This Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $772,626 to Brigham & Women's Hospital, a subsidiary of Partners Healthcare System, to conduct preclinical validation of gene therapy in mouse models of tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM). The research, which commenced on August 1, 2025 and is scheduled for completion by July 31, 2028, aims to transform healthcare for military service...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,844,306.00 Project Grant to the Regents of the University of Michigan on September 1, 2025. The grant, titled "COTARGETING NSD1/2 PARALOGS IN AR-DRIVEN CASTRATION-RESISTANT PROSTATE CANCER," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative medical...